• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Thursday, October 31, 2019

    Offline Date

    Thursday, April 30, 2020

    ACPE Expiration Date

    Monday, October 31, 2022

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      Colorectal cancer is the 3rd most common cancer in both men women in the United States.   Prevention and screening still continue to be at the forefront in helping deter this disease.  Treatment advances in colorectal cancer continue to benefit patients by introducing new pharmacologic modalities.   Immuno-oncology therapies are starting to play an increased role in certain colorectal cancers.   The purpose of this presentation will be to update the audience on the new pharmacologic advances in the treatment of colorectal cancer.

      Handouts

      • Slide Document :   ce_10_slides.pdf

      Financial Support By

      joint funding from Advanced Accelerator Applications, a Novartis Company, BMS and Pfizer Alliance, Celgene Corporation, Merck & Co., Inc, and Pfizer
    • Pharmacist

      Differentiate among treatment modalities used in various stages of colorectal cancer
      Recognize the incidence and prevalence of colorectal cancer therapies
      Identify the role of immune-oncology in colorectal cancer

      Nurse

      Identify the role of immune-oncology in colorectal cancer
      Differentiate among treatment modalities used in various stages of colorectal cancer
      Recognize the incidence and prevalence of colorectal cancer therapies
    • Activity Type

      Knowledge

      CE Broker

      20-747162

      Universal Activity Number

      Pharmacist 0798-0000-19-184-H01-P
      Nurse 0798-0000-19-184-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).